Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial
- Submitting institution
-
University College London
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 1757
- Type
- D - Journal article
- DOI
-
10.1016/S2213-8587(19)30086-5
- Title of journal
- The Lancet Diabetes and Endocrinology
- Article number
- -
- First page
- 429
- Volume
- 7
- Issue
- 6
- ISSN
- 2213-8587
- Open access status
- Compliant
- Month of publication
- April
- Year of publication
- 2019
- URL
-
-
- Supplementary information
-
https://ars.els-cdn.com/content/image/1-s2.0-S2213858719300865-mmc1.pdf
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
7
- Research group(s)
-
-
- Citation count
- 44
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
